Foundation president, Harvey Fineberg, and chairman emeritus and co-founder, Gordon Moore, discuss the Statement of Founders’ Intent with staff.
Moore Foundation Headquarters 1661 Page Mill Road, Palo Alto, CA 94304
To support the development of a clinical quality measure to improve diagnosis of pulmonary embolism.
Thank you for sharing.
Yale University, Department of Health Policy and Management
Field Testing a Patient Reported Measure for Diagnostic Quality in the Leapfrog Program
Yale University, Department of Chemical and Environmental Engineering
Green Chemistry Technologies for an Integrated Biorefinery
Yale University, Yale School of Medicine, Department of Emergency Medicine
Improving Equity of Lung Cancer Diagnosis Following Chest Imaging in the Emergency Department
Using Patient and Family Narratives of Diagnostic Errors to Inform Efforts to Improve Diagnosis
Yale University, Department of Chemistry
The Second Scialog: Chemical Machinery of the Cell II Research Competition
Yale University, Department of Mechanical Engineering and Materials Science
Judy Cha Materials Synthesis Investigator
Ivan Bozovic Materials Synthesis Investigator
Diagnostic Excellence Index for Pulmonary Embolism
Yale University, Yale School of Medicine, Department of Internal Medicine
Clinician and Patient Training in Patient Priority Care
Yale University, School of Forestry & Environmental Studies
Yale e360 Multimedia Redesign
Renewal: Yale e360
Yale University, Department of Applied Physics
Ivan Bozovic Materials Synthesis Investigator Award
Building Conservation Leadership and Expertise in the Amazon
Creating positive outcomes for future generations.